These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK. Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080 [TBL] [Abstract][Full Text] [Related]
7. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Bell JR; Eaton P; Shattock MJ Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505 [TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409 [TBL] [Abstract][Full Text] [Related]
9. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart. Gysembergh A; Simkhovich BZ; Kloner RA; Przyklenk K J Mol Cell Cardiol; 2001 Apr; 33(4):681-90. PubMed ID: 11273721 [TBL] [Abstract][Full Text] [Related]
10. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning. Marais E; Genade S; Salie R; Huisamen B; Maritz S; Moolman JA; Lochner A Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116 [TBL] [Abstract][Full Text] [Related]
11. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. Weinbrenner C; Liu GS; Cohen MV; Downey JM J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning. Schneider S; Chen W; Hou J; Steenbergen C; Murphy E Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H499-508. PubMed ID: 11158945 [TBL] [Abstract][Full Text] [Related]
15. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Fan WJ; van Vuuren D; Genade S; Lochner A Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248 [TBL] [Abstract][Full Text] [Related]
16. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926 [TBL] [Abstract][Full Text] [Related]
17. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning. Zhang Y; Gu EW; Zhang J; Chen ZW Chin Med J (Engl); 2007 May; 120(9):777-81. PubMed ID: 17531118 [TBL] [Abstract][Full Text] [Related]
18. SAPKs regulation of ischemic preconditioning. Sato M; Cordis GA; Maulik N; Das DK Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H901-7. PubMed ID: 10993748 [TBL] [Abstract][Full Text] [Related]
19. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. Saurin AT; Martin JL; Heads RJ; Foley C; Mockridge JW; Wright MJ; Wang Y; Marber MS FASEB J; 2000 Nov; 14(14):2237-46. PubMed ID: 11053245 [TBL] [Abstract][Full Text] [Related]
20. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]